Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Telomerase is a ribonucleoprotein complex which, by de novo synthesized telomeric TTAGGG repeats, prevents telomere erosion. While telomerase is active in most cancers, conflicting results exist for normal tissues and premalignant lesions. To establish the telomerase status of normal gastrointestinal mucosa and to elucidate whether telomerase up-regulation is an early or late event in carcinogenesis, we determined the telomerase activity of 88 biopsies of normal mucosa from esophagus, stomach, and intestine and compared it with that of 21 samples of premalignant lesions and 6 adenocarcinomas using the telomere-repeat amplification protocol assay. Telomerase was found in all normal tissues, revealing most activity in esophagus (11 samples), followed by intestine (45 samples), and stomach (32 samples). In 53% of the stomach samples, enzyme activity could only be demonstrated when telomerase inhibitors were eliminated by a modified telomerase assay. In the 21 precancerous lesions (5 Barrett's esophagus, 3 stomach intestinal metaplasias, and 13 colorectal adenomas of type I/II dysplasia) a similar or even reduced telomerase activity was seen, while the adenocarcinomas showed high activity. These data demonstrate that telomerase activity is expressed in all epithelia along the gastrointestinal tract, thus confirming our previous hypothesis that telomerase is constitutively expressed in permanently renewing epithelia. Furthermore, activity was not increased in preneoplastic lesions, suggesting that telomerase up-regulation is a late event during carcinogenesis of the esophagus, stomach, and intestine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, more sensitive analysis of primary human samples has since revealed modest levels of telomerase activity in proliferative tissues with high renewal potential such as the bone marrow, skin, gastrointestinal tract and testis as well as in activated lymphocytes (49)(50)(51).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · cited 2×
“…from normal epithelium to adenomas, and ®nally to adenocarcinomas, involves the functional loss of tumor-suppressor genes such as APC (adenomatous polyposis coli), DCC (deleted in colon carcinoma), and the p53 tumor-suppressor gene (Fearon and Vogelstein 1990; Vogelstein and Kinzler 1993).”
BackgroundSpecific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 8×
“Tissue samples were homogenized in 100 ll ice-cold 3-[3cholamidopropyl)dimethylamino]-propane sulfate (CHAPS), lysis buAer, using Eppendorf tubes and micropestles rotated by a drill at 450 rpm (Eppendorf, Hamburg, Germany) as described ( Kim et al. 1994 ).”
MethodResultInfluentialIdentification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 2×
“the specialized structures containing unique repetitive sequences (TTAGGG in vertebrates) at the end of chromosomes ( Greider and Blackburn 1985, 1989 ).”
BackgroundA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794 · cited 4×
“Since that time a great number of tumors of diAerent locations have been analyzed and about 85% have been found to be telomerase-positive (for review see Shay and Bacchetti 1997 ).”
BackgroundInfluentialThe multistep nature of cancer
Vogelstein, B., & Kinzler, K. W. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90209-z · Cited by 1,853 · cited 2×
“…from normal epithelium to adenomas, and ®nally to adenocarcinomas, involves the functional loss of tumor-suppressor genes such as APC (adenomatous polyposis coli), DCC (deleted in colon carcinoma), and the p53 tumor-suppressor gene (Fearon and Vogelstein 1990; Vogelstein and Kinzler 1993).”
BackgroundOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847 · cited 2×
“The enzyme compensates for the natural telomere erosion due to the inability of the DNA polymerase to replicate linear chromosomes completely (Watson 1972; Olovnikov 1973).”
BackgroundA telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643 · cited 1×
“Telomerase is a ribonucleprotein complex that elongates telomeres, i.e. the specialized structures containing unique repetitive sequences (TTAGGG in vertebrates) at the end of chromosomes (Greider and Blackburn 1985, 1989).”
BackgroundWATSON, J. D. (1972) · Nature New Biology · doi:10.1038/newbio239197a0 · Cited by 1,632 · cited 2×
“The enzyme compensates for the natural telomere erosion due to the inability of the DNA polymerase to replicate linear chromosomes completely (Watson 1972; Olovnikov 1973).”
BackgroundActivation of telomerase in human lymphocytes and hematopoietic progenitor cells
Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., & Yamakido, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3711 · Cited by 853 · cited 3×
“The majority of samples from esophagus, stomach, and colon were negative (Takubo et al. 1997; Maruyama et al. 1997; Tahara et al. 1995; Ahn et al. 1997; Hiyama E. et al. 1995; Chadeneau et al. 1995; Yoshida et al. 1997), while Hiyama and coworkers were able to demonstrate telomerase activity in all colon samples of he…”
MethodInfluentialTelomerase activity in normal and malignant hematopoietic cells
Broccoli, D., Young, J. W., & de Lange, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9082 · Cited by 567 · cited 1×
“As the ®rst example, telomerase activity was reported to be present in peripheral, cord blood, and bone marrow leukocytes (Counter et al. 1995; Broccoli et al. 1995; Hiyama K. et al. 1995).”
Background
Cited by
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Telomerase in the human organism
Collins, K., & Mitchell, J. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205083 · Cited by 603
“…tract and endometrium (Yasumoto et al., 1996; Taylor et al., 1996; HaÈ rle-Bachor and Boukamp, 1996; Hiyama et al., 1996; RamõÂ rez et al., 1997; Tanaka et al., 1998; Yokoyama et al., 1998; Bachor et al., 1999); and a subset of cells in the testis (Wright et al., 1996; Yashima et al., 1998).”
BackgroundThe molecular biology of cancer
Bertram, J. S. (2000) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00007-8 · Cited by 585
Telomere lengths are characteristic in each human individual
Takubo, K., Izumiyama-Shimomura, N., Honma, N., Sawabe, M., Arai, T., Kato, M., Oshimura, M., & Nakamura, K.-I. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00218-2 · Cited by 326
Mechanisms of Ultraviolet (UV) B and UVA Phototherapy
Krutmann, J., & Morita, A. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp.5640185 · Cited by 169
Metadata
- Authors
- Bachor, C., Bachor, O. A., & Boukamp, P.
- Affiliations
- German Cancer Research Center (DE)
- Klinikum Ludwigshafen (DE)
- ORCID
- Boukamp, Petra
- Venue
- Journal of Cancer Research and Clinical Oncology
- Published
- 1999-08-06
- Volume
- 125
- Issue
- 8-9
- Pages
- 453-460
- ISSN
- 0084-5353 (ISSN-L)
- 0171-5216
- 1432-1335
- PMC
- PMC12172385
- OpenAlex
- W2016779153
- Cited by
- 68
- References
- 30
- Citations by year
- 2021: 2 · 2020: 1 · 2018: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 1
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Cancer Research and Clinical Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Keywords
- telomerase, gastrointestinal mucosa, precancerous lesions, Barrett's esophagus, intestinal metaplasia, colorectal adenoma, adenocarcinoma, telomere repeat amplification protocol, carcinogenesis, esophagus, stomach, intestine, telomerase inhibitors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Gastric Mucosa, Gastrointestinal Neoplasms, Gene Amplification, Humans, Intestinal Mucosa, Male, Middle Aged, Up-Regulation, Gene Expression Regulation, Neoplastic, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions. https://app.cochat.ai/papers/10.1007/s004320050302
- The paper
- Bachor, C., Bachor, O. A., & Boukamp, P. (1999). Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s004320050302
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.